Biodexa Pharmaceuticals PLC Holds Annual General Meeting
Ticker: BDRX · Form: 6-K · Filed: Jun 27, 2025 · CIK: 1643918
| Field | Detail |
|---|---|
| Company | Biodexa Pharmaceuticals PLC (BDRX) |
| Form Type | 6-K |
| Filed Date | Jun 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: agm, corporate-governance, filing
TL;DR
Biodexa Pharma held its AGM on June 27, 2025. Standard corporate update.
AI Summary
Biodexa Pharmaceuticals PLC held its Annual General Meeting on June 27, 2025. The company, formerly known as Midatech Pharma Plc, is based in Cardiff, United Kingdom, and operates in the pharmaceutical preparations industry. The filing is a Form 6-K report for the month of June 2025.
Why It Matters
This filing confirms the date and occurrence of Biodexa's Annual General Meeting, a standard corporate governance event for publicly traded companies.
Risk Assessment
Risk Level: low — This is a routine corporate filing announcing the date of an Annual General Meeting, with no new financial or operational information provided.
Key Players & Entities
- Biodexa Pharmaceuticals PLC (company) — Registrant
- Midatech Pharma Plc (company) — Former company name
- June 27, 2025 (date) — Date of Annual General Meeting
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report the results of Biodexa Pharmaceuticals PLC's Annual General Meeting held on June 27, 2025.
When was Biodexa Pharmaceuticals PLC formerly known as?
Biodexa Pharmaceuticals PLC was formerly known as Midatech Pharma Plc, with a date of name change on June 2, 2015.
Where is Biodexa Pharmaceuticals PLC's principal executive office located?
Biodexa Pharmaceuticals PLC's principal executive offices are located at 1 Caspian Point, Caspian Way, Cardiff, CF10 4DQ, United Kingdom.
Which SEC form does Biodexa Pharmaceuticals PLC file its annual reports under?
Biodexa Pharmaceuticals PLC files its annual reports under cover of Form 20-F.
What is the standard industrial classification for Biodexa Pharmaceuticals PLC?
The standard industrial classification for Biodexa Pharmaceuticals PLC is Pharmaceutical Preparations [2834].
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 27, 2025 regarding Biodexa Pharmaceuticals Plc (BDRX).